foxo4-dri senolytic peptide human trial

foxo4-dri senolytic peptide human trial Buy (Proxofim) Peptide Inhibitors Targeting FOXO4-p53 Interactions

Name: foxo4-dri senolytic peptide human trial Buy (Proxofim) Peptide Inhibitors Targeting FOXO4-p53 Interactions
Brand: equiscorp.hu
SKU: 66058323731
Price: 26.54 USD
Availability: InStock
Rating: 4.2835 (27 reviews)

Peptide Inhibitors Targeting FOXO4 p53 Interactions and Inducing Senescent Cancer Cell specific Apoptosis Journal of Medicinal Chemistry GET RID OF ZOMBIE CELLS WITH FOXO4 DRI FOXO4 DRI is like a tiny tool scientists made to get rid of old, worn out cells in your body called senescent cells. These cells stop growing Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging PMC FOXO4 DRI (FOX04 DRI) 10mg Peptide Luxe Peptides

SKU: 66058323731 · From equiscorp.hu

4.3

USD26.54 USD51.54

Pay in 4 interest-free payments of $6.63 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 1 - Aug 6

Description

NNMT plays a key role in metabolic dysfunction, and its inhibition has been shown to reverse obesity-related changes in adipose tissue. Kraus et al., Cell Metabolism How 5-Amino-1MQ Works The primary mechanism behind 5-Amino-1MQ lies in its ability to inhibit nicotinamide N-methyltransferase (NNMT) an enzyme that is often overexpressed in fat cells, cancer cells, and aging tissues